What is AARD's price / book?

AARD (AARD) reported price / book of 0.9× in Q1 2026.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

AARD AARD Price / book

Price / book at other companies

AbbVieABBV

261×+221×

Relmada Therapeutics, Inc.RLMD

3.3×+2.9×

Rhythm Pharmaceuticals, Inc.RYTM

48.3×-128×

Viking TherapeuticsVKTX

7.5×+4.3×

ArvinasARVN

1.8×+1.0×

Protagonist TherapeuticsPTGX

10.3×+6.0×

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

market cap/total stockholders equity=0.9×

Based on the most recent quarter.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's price / book?: AARD (AARD) reported price / book of 0.9× in Q1 2026.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.